Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

FPP 003

Next Previous
Search
Drug Profile

FPP 003

Alternative Names: FPP-003; IL17A vaccine - FunPep

Latest Information Update: 02 Aug 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator FunPep; Osaka University School of Medicine
  • Class Anti-inflammatories; Antipsoriatics; Peptide vaccines; Peptides
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase I/II Psoriasis
  • Phase I Ankylosing spondylitis

Most Recent Events

  • 12 Jun 2024 Immunogenicity and adverse events data from a phase I trial in Ankylosing spondylitis presented at the 25th Annual Congress of the European League Against Rheumatism (EULAR-2024)
  • 18 Jul 2023 Phase-I clinical trials in Ankylosing spondylitis in Japan (SC) (FunPep pipeline, July 2023)
  • 28 May 2023 No recent reports of development identified for preclinical development in Spondylarthritis in Japan (SC, Injection)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top